Research programme: sexual dysfunction therapy - Melacure
Alternative Names: Sexual dysfunction therapy research programme - MelacureLatest Information Update: 02 Aug 2006
Price :
$50 *
At a glance
- Originator Melacure Therapeutics (CEASED)
- Class
- Mechanism of Action Melanocortin receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Female sexual dysfunction; Male sexual dysfunction
Most Recent Events
- 02 Aug 2006 No development reported - Preclinical for Female sexual dysfunction in Sweden (unspecified route)
- 02 Aug 2006 No development reported - Preclinical for Male sexual dysfunction in Sweden (unspecified route)
- 16 Jul 2003 Preclinical trials in Female sexual dysfunction in Sweden (unspecified route)